CNST Insider Trading Activity and SEC Form 4 Filings
CNST insider trading summary
No open-market insider purchases or sales of Constellation Pharmaceuticals Inc (CNST) have been reported on SEC Form 4 in the past 12 months.
Latest CNST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 22, 2021 | Emma Reeve | Chief Financial Officer | Sell | $235K (6,260 @ $37.60) |
| Feb 19, 2021 | Emma Reeve | Chief Financial Officer | Sell | $151K (4,010 @ $37.71) |
| Feb 18, 2021 | Emma Reeve | Chief Financial Officer | Sell | $41K (1,100 @ $37.58) |
| Feb 17, 2021 | Ponoi Management, LLC | 10% Owner | Sell | $370K (10,000 @ $36.95) |
| Feb 17, 2021 | David V Goeddel | 10% Owner | Sell | $370K (10,000 @ $36.95) |
| Feb 17, 2021 | Column Group III, LP | 10% Owner | Sell | $370K (10,000 @ $36.95) |
| Feb 17, 2021 | Peter Svennilson | 10% Owner | Sell | $370K (10,000 @ $36.95) |
| Feb 17, 2021 | Column Group Iii-A, LP | 10% Owner | Sell | $370K (10,000 @ $36.95) |
| Feb 17, 2021 | Column Group Gp, LP | 10% Owner | Sell | $370K (10,000 @ $36.95) |
| Feb 17, 2021 | Column Group L P | 10% Owner | Sell | $370K (10,000 @ $36.95) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.